Speaker illustration

Associate Professor Masaru Hatano

University of Tokyo Hospital, Tokyo (Japan)

Member of:

European Society of Cardiology

Identification of predictors of response to initial oral combination therapy in WHO-functional class II or III PAH patients: A post-hoc analysis of the AMBITION study

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Pulmonary Hypertension

Session: Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure ePosters

Thumbnail

This platform is supported by

logo Novo Nordisk